PLAY PODCASTS
Why Not Give The Weight Loss Industry the Benefit of the Doubt? Part 2 - GLP-1 Weight Loss Drugs

Why Not Give The Weight Loss Industry the Benefit of the Doubt? Part 2 - GLP-1 Weight Loss Drugs

Weight and Healthcare · Ragen Chastain

May 24, 20255m 55s

Audio is streamed directly from the publisher (api.substack.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In part 1 we discussed the general issues with giving the weight loss industry the benefit of the doubt. Today we are going to talk about this as it applies to GLP-1s. This started with an email I got from Elena:

I’m a weight-neutral family doctor. I was talking to a colleague about my issues with the GLP-1s and how there is no evidence that supports that taking them for life will lead to sustained weight loss or health benefits. He said “There’s no evidence that they won’t.” It strikes me as wrong, but how do I argue with that.

Here I’m going to suggest that it doesn’t just feel wrong, it IS wrong on several levels.



Get full access to Weight and Healthcare at weightandhealthcare.substack.com/subscribe